Catherine Ivory

404 total citations
17 papers, 302 citations indexed

About

Catherine Ivory is a scholar working on Infectious Diseases, Immunology and Parasitology. According to data from OpenAlex, Catherine Ivory has authored 17 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 5 papers in Immunology and 4 papers in Parasitology. Recurrent topics in Catherine Ivory's work include Parasitic Infections and Diagnostics (4 papers), Amoebic Infections and Treatments (4 papers) and Spondyloarthritis Studies and Treatments (2 papers). Catherine Ivory is often cited by papers focused on Parasitic Infections and Diagnostics (4 papers), Amoebic Infections and Treatments (4 papers) and Spondyloarthritis Studies and Treatments (2 papers). Catherine Ivory collaborates with scholars based in Canada, Türkiye and United Kingdom. Catherine Ivory's co-authors include Kris Chadee, Donna‐Marie McCafferty, Laurie E. Wallace, David L. Sigalet, Christian Jobin, Kathy Keller, Penny Phillips, Sibel Zehra Aydın, Gordon Rustin and K. D. Bagshawe and has published in prestigious journals such as Gastroenterology, Infection and Immunity and Annals of the Rheumatic Diseases.

In The Last Decade

Catherine Ivory

15 papers receiving 293 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine Ivory Canada 8 95 94 87 64 48 17 302
Ivana Ferreira Australia 8 110 1.2× 276 2.9× 41 0.5× 79 1.2× 62 1.3× 11 442
Jean‐Gérard Gobert France 10 99 1.0× 110 1.2× 65 0.7× 63 1.0× 21 0.4× 11 348
Espiridión Ramos-Martı́nez Mexico 14 164 1.7× 184 2.0× 67 0.8× 149 2.3× 41 0.9× 38 568
Heloísa Nascimento Brazil 16 83 0.9× 114 1.2× 31 0.4× 19 0.3× 99 2.1× 73 766
Patrick Merky Sweden 7 66 0.7× 113 1.2× 38 0.4× 244 3.8× 13 0.3× 9 508
Bert Mohr South Africa 9 87 0.9× 53 0.6× 49 0.6× 13 0.2× 21 0.4× 18 317
Kristin E. Killoran United States 10 112 1.2× 95 1.0× 47 0.5× 150 2.3× 10 0.2× 15 393
A A Mahmoud United States 9 58 0.6× 283 3.0× 41 0.5× 103 1.6× 114 2.4× 12 471
Gerard McLauchlan United Kingdom 8 28 0.3× 54 0.6× 58 0.7× 18 0.3× 14 0.3× 20 341
Kioko Takei Brazil 11 39 0.4× 54 0.6× 15 0.2× 40 0.6× 30 0.6× 23 287

Countries citing papers authored by Catherine Ivory

Since Specialization
Citations

This map shows the geographic impact of Catherine Ivory's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Ivory with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Ivory more than expected).

Fields of papers citing papers by Catherine Ivory

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Ivory. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Ivory. The network helps show where Catherine Ivory may publish in the future.

Co-authorship network of co-authors of Catherine Ivory

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Ivory. A scholar is included among the top collaborators of Catherine Ivory based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Ivory. Catherine Ivory is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aydın, Sibel Zehra, et al.. (2024). AB0540 TREAT (DEPRESSION TO REACH)-TO-TARGET IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases. 83. 1548–1549.
2.
Ivory, Catherine, et al.. (2023). Concurrence of familial Mediterranean fever and Behçet’s disease: a case report and review of the literature. Journal of Medical Case Reports. 17(1). 438–438. 1 indexed citations
3.
Ivory, Catherine, et al.. (2022). Factors affecting patient satisfaction with outpatient rheumatology phone visits during the COVID-19 pandemic. Clinical Rheumatology. 41(9). 2839–2844. 5 indexed citations
4.
Ivory, Catherine, et al.. (2021). Mixed connective tissue disease after thymectomy in refractory myasthenia gravis. Rheumatology International. 42(11). 2077–2084.
5.
Maltez, Nancy, et al.. (2021). Use of subcutaneous immunoglobulin in inflammatory myositis. Rheumatology Advances in Practice. 5(3). rkab070–rkab070. 2 indexed citations
6.
Solmaz, Dilek, et al.. (2020). Accuracy of Physical Examination to Detect Synovial and Extra-Synovial Pathologies in Psoriatic Arthritis in Comparison to Ultrasonography. Journal of Clinical Medicine. 9(9). 2929–2929. 4 indexed citations
7.
Chin, Melanie, et al.. (2019). A severe pleural complication associated with granulomatosis with polyangiitis. Respiratory Medicine Case Reports. 28. 100933–100933. 2 indexed citations
8.
Smith, D.P., et al.. (2018). Development of lupus nephritis in a patient with previous scleroderma renal crisis. Lupus. 27(10). 1732–1734. 2 indexed citations
9.
Bakırcı, Sibel, Catherine Ivory, Umut Kalyoncu, Jacob Karsh, & Sibel Zehra Aydın. (2018). What does evidence-based medicine tell us about treatments for different subtypes of psoriatic arthritis? A systematic literature review on randomized controlled trials. Rheumatology Advances in Practice. 2(1). rkx019–rkx019. 7 indexed citations
10.
Ivory, Catherine, Laurie E. Wallace, Donna‐Marie McCafferty, & David L. Sigalet. (2008). Interleukin-10-independent anti-inflammatory actions of glucagon-like peptide 2. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(6). G1202–G1210. 72 indexed citations
11.
Ivory, Catherine, Laurie E. Wallace, Elaine de Heuvel, & David L. Sigalet. (2008). T1205 Glucagon-Like Peptide-2 Improves Healing of TNBS Colitis By Altering Immune Regulatory Cell Signaling in the Lamina Propria. Gastroenterology. 134(4). A–506. 1 indexed citations
12.
Ivory, Catherine, et al.. (2007). Toll-Like Receptor 9-Dependent Macrophage Activation by Entamoeba histolytica DNA. Infection and Immunity. 76(1). 289–297. 40 indexed citations
13.
Ivory, Catherine & Kris Chadee. (2007). Activation of dendritic cells by the Gal‐lectin of Entamoeba histolytica drives Th1 responses in vitro and in vivo. European Journal of Immunology. 37(2). 385–394. 34 indexed citations
14.
Ivory, Catherine & Kris Chadee. (2007). Intranasal Immunization with Gal-Inhibitable Lectin plus an Adjuvant of CpG Oligodeoxynucleotides Protects against Entamoeba histolytica Challenge. Infection and Immunity. 75(10). 4917–4922. 15 indexed citations
15.
Ivory, Catherine, Kathy Keller, & Kris Chadee. (2005). CpG-Oligodeoxynucleotide Is a Potent Adjuvant with anEntamoeba histolyticaGal-Inhibitable Lectin Vaccine against Amoebic Liver Abscess in Gerbils. Infection and Immunity. 74(1). 528–536. 24 indexed citations
16.
Ivory, Catherine & Kris Chadee. (2004). DNA vaccines: designing strategies against parasitic infections. PubMed. 2(1). 17–17. 77 indexed citations
17.
Rustin, Gordon, et al.. (1990). Respiratory failure due to choriocarcinoma: A study of 103 dyspneic patients. Gynecologic Oncology. 38(2). 149–154. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ivana Ferreira Breakdown of academic impact, for papers by Jean‐Gérard Gobert Breakdown of academic impact, for papers by Espiridión Ramos-Martı́nez Breakdown of academic impact, for papers by Heloísa Nascimento Breakdown of academic impact, for papers by Patrick Merky Breakdown of academic impact, for papers by Bert Mohr Breakdown of academic impact, for papers by Kristin E. Killoran Breakdown of academic impact, for papers by A A Mahmoud Breakdown of academic impact, for papers by Gerard McLauchlan Breakdown of academic impact, for papers by Kioko Takei
Rankless by CCL
2026